Polymeric nanoformulations aimed at cancer metabolism reprogramming with high specificity to inhibit tumor growth

Yu Xia, Ming-kang Zhang, Jing-jie Ye, Mei-ting Niu, Zi-yang Wang, Xin-yi Dai, Zhi-ling He and Jun Feng

Biomater. Sci., 2024, 12, 5076
DOI: 10.1039/D4BM00887A

Engineering lactate-modulating nanomedicines for cancer therapy

Jiajie Chen, Yufang Zhu, Chengtie Wu and Jianlin Shi

Chem. Soc. Rev., 2023, 52, 973
DOI: 10.1039/D2CS00479H

A Biomimetic Microparticle Disrupting the Intracellular/Extracellular pH Homeostasis of Tumor Cells for Cancer Chemo-Immunotherapy

Liping Zuo, Ya Zhao, Zhou Huang, Danyu Wang, Fei Xu, Mengchi Zhang, Shuo He and Kuikun Yang

ACS Nano, 2026, 20, 7928
DOI: 10.1021/acsnano.5c22145

Programmed Targeting Pyruvate Metabolism Therapy Amplified Single‐Atom Nanozyme‐Activated Pyroptosis for Immunotherapy

Rui Niu, Yang Liu, Bo Xu, Ruiping Deng, Shijie Zhou, Yue Cao, Wanying Li, Hao Zhang, Haiyang Zheng, Shuyan Song, Yinghui Wang and Hongjie Zhang

Advanced Materials, 2024, 36
DOI: 10.1002/adma.202312124

Advanced nanomaterials for enhanced immunotherapy via metabolic regulation

Xinyang Li, Binbin Ding, Pan Zheng, Ping'an Ma and Jun Lin

Coordination Chemistry Reviews, 2024, 500, 215540
DOI: 10.1016/j.ccr.2023.215540

Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics

Asif Shahzad, Zhuoran Teng, Muhammad Yameen, Wenjing Liu, Kun Cui, Xiangjie Liu, Yijian Sun, Qiuxin Duan, JiaoJiao Xia, Yurong Dong, Ziyuan Bai, Dongmei Peng, Jinshan Zhang, Zhe Xu, Jiang Pi, Zhe Yang and Qiao Zhang

Biomedicine & Pharmacotherapy, 2024, 180, 117465
DOI: 10.1016/j.biopha.2024.117465

Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma

Jia-tao Yao, Peng-cheng Hu, Xiao-wei Li, Jia-cheng Xu, Ke-jie Wang, Sha-zhou Ye, Xiang-yu Meng, Hai-chao Chen, Yu Liang and Qi Ma

Genes & Diseases, 2025, 101991
DOI: 10.1016/j.gendis.2025.101991

MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p

Alessandra Affinito, Cristina Quintavalle, Rosario Vincenzo Chianese, Giuseppina Roscigno, Danilo Fiore, Valeria D’Argenio, Guglielmo Thomas, Alessia Savarese, Francesco Ingenito, Lorenza Cocca, Silvia Nuzzo, Maxim V. Berezovski, Maria Patrizia Stoppelli and Gerolama Condorelli

Cell Death Discov., 2024, 10
DOI: 10.1038/s41420-024-01910-x

Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis

Shanshan Yang, Miaomiao Lin, Shaodong Hao, Hui Ye and Xuezhi Zhang

Front. Immunol., 2024, 15
DOI: 10.3389/fimmu.2024.1497461

Influence of lactate in resistance to anti‑PD‑1/PD‑L1 therapy: Mechanisms and clinical applications (Review)

Yi Zeng, Yu Huang, Qiaoyun Tan, Ling Peng, Jian Wang, Fan Tong and Xiaorong Dong

Mol Med Rep, 2024, 31
DOI: 10.3892/mmr.2024.13413

The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies

Yuganthini Vijayanathan and Ivy A. W. Ho

IJMS, 2025, 26, 669
DOI: 10.3390/ijms26020669

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

Hailong Tian, Jiangjun Cao, Bowen Li, Edouard C. Nice, Haijiao Mao, Yi Zhang and Canhua Huang

Bone Res, 2023, 11
DOI: 10.1038/s41413-023-00246-z

Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications

Peiting Wu, Juan Zhang, Zhengwu Jiang, Xueru Liu, Ni Jiang, Juan Zou, Xun Chen, Daichao Wu and Yukun Li

Biomark Res, 2026, 14
DOI: 10.1186/s40364-026-00898-z

Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies

Xiaojie Zhang, Min An, Juntao Zhang, Yumeng Zhao and Yanhua Liu

Journal of Drug Targeting, 2024, 32, 241
DOI: 10.1080/1061186X.2024.2309565

The role of lactylation in breast cancer development: mechanisms, clinical translation and new strategies for treatment

Yanzhen Lu, Xiaoting Yang, Lulu Tan, Yunfei Yang, Dan Yu, Gang Feng and Yuyan Tan

Front. Oncol., 2025, 15
DOI: 10.3389/fonc.2025.1665097

Nanomaterials-involved strategies for reversing the immunosuppressive factors and improving antitumor immunotherapy

Fan Gao, JianHui Dong, Chun Xue, Lei An, Tian Zhang, Wen-Jun Wang, ChangJin Ou and XiaoChen Dong

Nano Today, 2023, 50, 101831
DOI: 10.1016/j.nantod.2023.101831

NK cell-based tumor immunotherapy

Hao Zhang, Li Yang, Tingting Wang and Zhen Li

Bioactive Materials, 2024, 31, 63
DOI: 10.1016/j.bioactmat.2023.08.001

Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy

Qian Cheng, Xiao‐Lei Shi, Qi‐Lin Li, Lin Wang and Zheng Wang

Advanced Science, 2024, 11
DOI: 10.1002/advs.202305662

Biodegradable copper peroxide decorated hollow polydopamine nanocomposite as effective chloroperoxidase delivery carrier for enhancing enzyme dynamic therapy via self-activated cascade reactions

Weiwei Wu, Yan Yang, Yu Zhang, Yina Zeng, Zhuoying Liang, Xiling Song, Yadong Huang, Wei Xue and Siming Yu

Chemical Engineering Journal, 2024, 481, 148113
DOI: 10.1016/j.cej.2023.148113

Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling

Wencong Ma, Cheng Zhang, Anjiang Gou, Mingtai Hu, Yao Huang, Xiaoqing Jiang, Jianyang Ao and Jinghan Wang

Translational Oncology, 2026, 65, 102678
DOI: 10.1016/j.tranon.2026.102678

Smart Design of Nanostructures for Boosting Tumor Immunogenicity in Cancer Immunotherapy

Bohan Yin, Wai-Ki Wong, Yip-Ming Ng, Mo Yang, Franco King-Chi Leung and Dexter Siu-Hong Wong

Pharmaceutics, 2023, 15, 1427
DOI: 10.3390/pharmaceutics15051427

Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy

Weizhi Chen, Cheng Li and Xiqun Jiang

Small Methods, 2023, 7
DOI: 10.1002/smtd.202201404

Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor

Rui Han, Hongxing Yang, Changquan Ling and Lingeng Lu

Cancer Cell Int, 2022, 22
DOI: 10.1186/s12935-022-02786-6

The effect of lactate dehydrogenase inhibitors on proliferation, motility and invasion of breast cancer cells in vitro highlights a new role for lactate

Maitham Khajah, Sarah Khushaish and Yunus Luqmani

Mol Med Rep, 2023, 29
DOI: 10.3892/mmr.2023.13135

Mechanisms and intervention strategies of microenvironment-mediated drug resistance in multiple myeloma

Zhu Xiaoling, Chen Qi, Yan Tingting, He Di and Yu Meijia

Cancer Cell Int, 2026, 26
DOI: 10.1186/s12935-026-04188-4

PEG‐Sheddable Nanodrug Remodels Tumor Microenvironment to Promote Effector T Cell Infiltration and Revise Their Exhaustion for Breast Cancer Immunotherapy

Tao Huang, Qiaoyun Zhang, Jing Yi, Rongze Wang, Zekun Zhang, Pin Luo, Rong Zeng, Yong Wang and Mei Tu

Small, 2023, 19
DOI: 10.1002/smll.202301749

Lactate and lactylation in cancer

Jie Chen, Ziyue Huang, Ya Chen, Hao Tian, Peiwei Chai, Yongning Shen, Yiran Yao, Shiqiong Xu, Shengfang Ge and Renbing Jia

Sig Transduct Target Ther, 2025, 10
DOI: 10.1038/s41392-024-02082-x

Lactylation in cancer: Advances and opportunities for treatment resistance

Keke Xu, Yiyi Shou, Ruiqi Liu, Hao Xiong, Xiaomeng Dai, Xuanwen Bao, Xiaoyan Chen, Luanluan Huang, Hailong Sheng, Haibo Zhang and Yanwei Lu

Clinical & Translational Med, 2025, 15
DOI: 10.1002/ctm2.70478

Hypoxia-induced immunosuppression in uveal melanoma is mediated by CD63+ exosomes delivering lactate to reprogram immune cells

Lei Dong, Suilian Zheng and Yixia Feng

Front. Mol. Biosci., 2026, 12
DOI: 10.3389/fmolb.2025.1743009

Recent advances in non-alcoholic steatohepatitis-associated hepatocellular carcinoma: immune cells, metabolic dysregulation, and therapeutic strategies

Lisi Liu, Xun Duan and Baozhao Ju

Front. Oncol., 2026, 15
DOI: 10.3389/fonc.2025.1744299

FGFR1 suppresses ovarian cancer progression by modulating SIRT3-dependent lactylation and metabolic reprogramming

Fan Jiang, Huaju Huang, Zhe Dong, Lu Zhang, Shiti Zhang, Mengnan Long, Xue Fan, Nan Li and Hao Ai

Cell Death Discov., 2026
DOI: 10.1038/s41420-026-03054-6

An enzyme-instructed self-assembly system induces tumor acidosis via sequential-dual effect for cancer selective therapy

Hao Zhang, Zhilong Wang, Tongxin Gao, Zhongyan Wang, Chunhua Ren and Jianfeng Liu

Acta Biomaterialia, 2023, 164, 447
DOI: 10.1016/j.actbio.2023.03.036

Modulation of glucose metabolism through macrophage-membrane-coated metal-organic framework nanoparticles for triple-negative breast cancer therapy

Qing Yao, Jinyao Ye, Yahui Chen, Lihui Huang, Lining Sun, Zhinan He, Jianing Wu, Yingyi Zhao, Xinyu Zhao, Aimin Cai, Xiandan Chen, Hailun Zheng, Aliaksei Sysa, Congying Xie, Ruijie Chen and Longfa Kou

Chemical Engineering Journal, 2024, 480, 148069
DOI: 10.1016/j.cej.2023.148069

Targeting tumor-associated macrophage polarization with traditional Chinese medicine active ingredients: Dual reversal of chemoresistance and immunosuppression in tumor microenvironment

Yafeng Qi, Jingnan Yan, Xixi Huang, Xiaodan Jiang, Rongrong Li, Jiayi Wan, Yangyang Li, Zhiming Miao, Zhongyang Song, Yongqi Liu, Liying Zhang and Zhiming Zhang

Pharmacological Research, 2025, 216, 107788
DOI: 10.1016/j.phrs.2025.107788

Disrupting tumor homeostasis with an autoamplificatory nanoinducer to augment pyroptosis for efficient immunotherapy

Qiaoling Zhang, Ling Lin, Gui Chen, Minyi Nie, Guimei Chen, Yan Tang, Huiyang Chen, Yuanyuan Yang, Zhiqiang Yu, Xing-Jie Liang and Zhenwei Peng

Biomaterials, 2026, 324, 123544
DOI: 10.1016/j.biomaterials.2025.123544

Lactylation in cancer: molecular mechanisms and advances in clinical study

Jiale Li, Changfeng Miao, Haijun Guo, Maximo Lin, Rui Chen, Jun Peng, Jiachong Wang, Chunhai Tang and Zigui Chen

Mol Cancer, 2026, 25
DOI: 10.1186/s12943-026-02573-1

Metabolism, metabolites, and macrophages in cancer

Mengyuan Li, Yuhan Yang, Liting Xiong, Ping Jiang, Junjie Wang and Chunxiao Li

J Hematol Oncol, 2023, 16
DOI: 10.1186/s13045-023-01478-6

Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI

Shuai Fan, Wenyu Wang, Wenbo Che, Yicheng Xu, Chuan Jin, Lei Dong and Qin Xia

Metabolites, 2025, 15, 201
DOI: 10.3390/metabo15030201

Construction and Assessment of a Prognostic Risk Model for Cervical Cancer Based on Lactate Metabolism-Related lncRNAs

Ya Gao, Hongyang Liu, Junhu Wan, Fenghua Chang, Lindong Zhang, Wenjuan Wang, Qinshan Zhang and Quanling Feng

IJGM, 2023, Volume 16, 2943
DOI: 10.2147/IJGM.S411511

Advances in tumor immunotherapy targeting macrophages

Binrui Shi, Meng Du and Zhiyi Chen

Expert Review of Clinical Immunology, 2025, 21, 259
DOI: 10.1080/1744666X.2024.2438721

Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy

Wen Zhang, Xueyin Hu, Wei Cheng, Lumeng Zhang, Yuanfang Chen, Qinrui Fu, Luntao Liu and Saijun Fan

BMEMat, 2026, 4
DOI: 10.1002/bmm2.70019

Enhancing melanoma therapy by modulating the immunosuppressive microenvironment with an MMP-2 sensitive and nHA/GNE co-encapsulated hydrogel

Zhu Chen, Hongfeng Wu, Yifu Wang, Yunjia Rao, Jin Yan, Bin Ran, Qin Zeng, Xiao Yang, Jun Cao, Huan Cao, Xiangdong Zhu and Xingdong Zhang

Acta Biomaterialia, 2024, 188, 79
DOI: 10.1016/j.actbio.2024.08.055

Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights

Wen Xiao, Dan Tan, Wen Zeng, Xiaoming Nie and Mingliang Wang

Genes & Diseases, 2026, 102054
DOI: 10.1016/j.gendis.2026.102054

Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects

Hanwen Zhang, Oliver Felthaus, Andreas Eigenberger, Silvan Klein and Lukas Prantl

Cells, 2024, 13, 1526
DOI: 10.3390/cells13181526